Posted on 03/27/2020 7:57:17 AM PDT by SeekAndFind
President Trump has turned to a French virologist with a history of criticizing climate science to offer the world hope amid the novel coronavirus pandemic.
Last week, Trump tweeted that the combination of two medicines could dramatically alter the often deadly course of COVID-19.
"HYDROXYCHLOROQUINE & AZITHROMYCIN, taken together, have a real chance to be one of the biggest game changers in the history of medicine," Trump wrote. He then cited a study published in the International Journal of Antimicrobial Agents that afforded little time for peer review.
Trump's optimism comes from a small study of about 40 COVID-19 patients in France, though it wasn't immediately clear how it came to the president's attention.
The study was conducted by Didier Raoult, a virologist at Aix-Marseille University in France. Raoult has a history of challenging science outside of his field of expertise, including claims that Darwin's theory of evolution was wrong and that climate models are overblown.
"Climate predictions are absurd," he wrote in a 2013 piece for a French publication, Le Point, in which Raoult declared he "hates climate forecasts."
According to a French-to-English translation, he wrote that those who take action against climate change as well as those who do the research to examine it have taken "more of a religious approach than a science."
"Our sense of guilt explains the transformation of the debate into something of an unscientific nature," he wrote.
While Raoult has no climate credentials, he is an influential virologist who has discovered dozens of bacteria. Raoult also has been critical of how governments have responded to the global pandemic, and he published a book this month called "Epidemics, Real Dangers and False Alarms."
In it, he blames the media for instilling fear about COVID-19. "This panic is largely due to the exaggerations of the press, which knows that fear 'sells,'" he wrote.
It remains to be seen if Raoult has discovered a useful and potentially lifesaving drug regime to combat the coronavirus, health experts caution. They include Dr. Anthony Fauci, a member of Trump's coronavirus task force who said researchers don't know yet if the drugs are safe for people with the coronavirus.
Health ethicists say Raoult's work, and other small studies, should not be reflexively touted as a cure particularly by politicians looking to give people an unverified sense of hope.
Hydroxychloroquine is a derivative of an anti-malaria drug, and azithromycin is an antibiotic used to treat bacterial pneumonia.
Raoult, an influential virologist who has received funding from the French government, published a video in February called "Coronavirus: Endgame!" in which he explored Chinese experiments with hydroxychloroquine.
He quickly tested it on a small group of French COVID-19 patients in a local hospital earlier this month and, along with a group of co-authors, published his research March 20, after a day of peer review, in the International Journal of Antimicrobial Agents.
The study recommended that all COVID-19 patients be treated with the drug cocktail, even though no larger regime of testing has been conducted.
Malarial drugs can have significant side effects in some patients, including retinal failure and cardiac arrest. Despite the dramatic pronouncement that hundreds of thousands of coronavirus patients should be administered the drugs, Raoult and his co-authors acknowledged the limitations of their research.
"Our study has some limitations including a small sample size, limited long-term outcome follow-up, and dropout of six patients from the study, however in the current context, we believe that our results should be shared with the scientific community," they wrote.
A study published this week in the Journal of Zhejiang University in China contradicted the Raoult study and found that hydroxychloroquine was not any more effective than conventional coronavirus treatment. Both studies rely on a small group of patients.
The embrace of limited-research results by politicians can be dangerous, said Alison Bateman-House, a health ethicist and professor of population health at New York University.
She said there is precedent for taking unproven research when other options are not available but that it should not be touted by politicians as a solution before that is proved.
"It's incredibly irresponsible, and it's not something any leader should be doing," she said. "If you're not a physician, you shouldn't be opining on medical care."
Not conducting research with clear guidelines means the end result may not provide the scientific backing that is needed to use the treatment on a wider scale, said Bateman-House.
"If you're not giving people these medications in a well-structured, thought-out trial that has the support and capabilities necessary to collecting the data, then you're not advancing the science, all you're getting is more anecdotal evidence," she said.
Nonetheless, Trump and Vice President Mike Pence have spent days touting this option.
"Doctors can now prescribe chloroquine for that off-label purpose of dealing with the symptoms of coronavirus," Pence told reporters Saturday. "The president's very optimistic."
Those claims may have contributed to a run on the drugs throughout the world.
Pharmacies across Africa, where malarial medications often are a matter of life or death, saw a high demand for the drug.
And the pressure to obtain the drugs in the United States has become so severe that pharmacy boards in Idaho, Kentucky, Ohio, Nevada, Oklahoma, North Carolina and Texas have issued new guidance on how the drugs should be administered, according to a New York Times article.
The Washington Post reported yesterday that Mark Meadows, Trump's incoming chief of staff, reached out to a family doctor in upstate New York who said he has used the drugs to treat hundreds of suspected coronavirus cases.
Conservative media outlets and Fox News host Sean Hannity have touted the work of that family doctor from New York, Vladimir Zelenko. Zelenko has also used his Facebook page to say that China is using the coronavirus as a population control device.
At least one state, however, is giving the drugs a chance.
New York is now conducting a large-scale experiment, distributing the drug throughout its hospital networks to try on sick patients, and Gov. Andrew Cuomo (D) has ordered hundreds of thousands of doses. The Food and Drug Administration, at Trump's urging, has rapidly approved the testing.
Raoult is confident his work will hold up.
"In my field, I am a star, worldwide," Raoult told the La Provence newspaper in France. "I don't give a damn what others think. I am not an outsider. I'm streaks ahead of the others."
Being a climate skeptic enhances his credibility.
Talk about a headline utterly irreverent to the story.
Gee someone who understand Science finally. Nice to met you Dr Raoult
“Our sense of guilt explains the transformation of the debate into something of an unscientific nature,”
So true.
A DENIER?! Oh noooooooo!
yeah trump is relying on one and only one guy who he can’t even talk to. The BS is becoming a Tsunami.
Now I REALLY put stock in Didier.
Scott has no science
Fake presstitute
Coronavirus: Health Ministry Declares Hydroxychloroquine A Schedule H1 Drug; Heres What It Means (India declares it “essential” for treatment for CORVID-19)
Watch the media start complaining that in desperation Trump has turned to an anti-science climate denier to support his lies to the American people so that he can further push his selfish and murderous COVID-19 agenda.
The writer’s hatred is such that he even criticizes hope if it’s from President Trump.
The current conventional wisdom group think is not having a lot of success so far
Hide the Decline
In todays world being a climate skeptic is on par with being a Holocaust denier.
Meanwhile medical reports are very positive about this medicine and India has just reserved all its pills for domestic use during this virus scare. India makes a lot of these pills, incidentally. Israel just sent a large supply of these pills free to USA to help against this virus as Israel is using them too and so are several other counties including . FDA likewise says any USA doctor can prescribe this medicine. China is using it too. Abstract
The coronavirus disease 2019 (COVID-19) virus is spreading rapidly, and scientists are endeavoring to discover drugs for its efficacious treatment in China. Chloroquine phosphate, an old drug for treatment of malaria, is shown to have apparent efficacy and acceptable safety against COVID-19 associated pneumonia in multicenter clinical trials conducted in China. The drug is recommended to be included in the next version of the Guidelines for the Prevention, Diagnosis, and Treatment of Pneumonia Caused by COVID-19 issued by the National Health Commission of the People’s Republic of China for treatment of COVID-19 infection in larger populations in the future.
Keywords: 2019-nCoV; COVID-19; SARS-CoV-2; chloroquine; pneumonia.
He wasnt the only one - Norway did a small double blind study that was also showed success.
This isnt science - this is scientism, a religious following like climate science where non-believers are cast out as evil.
And you have their priests like the governor of Michigan and Nevada penalizing doctors who want to at least try to use the drug on terminal patients but are forbidden now to do so because it upsets the orthodoxy.
Agree. It boosts his bonafides to me.
What is a Class 1 climate skeptic?
Someone who can do actual science, but is NOT being funded to do climate “research” by the government.
What is a Class 2 climate skeptic?
Someone who considers EVERYTHING about climate from the media to be tainted, half-witted, and presented by folks who failed their fifth grade science tests.
As he should.
“Being a climate skeptic enhances his credibility.”
Exactly! My opinion of him just went up.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.